News from roche canada A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
Latest
Aug 13, 2019, 08:00 ET Health Canada approves Tecentriq® (atezolizumab), first new treatment in 20 years for aggressive form of lung cancer(1)
Data show Tecentriq in combination with carboplatin and etoposide helped patients with extensive-stage small cell lung cancer live longer, with a 30% reduction in the risk of death2 MISSISSAUGA, ON,...
Jun 18, 2019, 07:59 ET Health Canada Approves Hemlibra® for Hemophilia A Patients Without Factor VIII Inhibitors
Hemlibra is the only treatment that can be self-injected subcutaneously once weekly for patients with hemophilia A without factor VIII inhibitors1 MISSISSAUGA, ON, June 18, 2019 /CNW/ - Hoffmann-La...
Mar 19, 2019, 10:00 ET Roche and the pan-Canadian Pharmaceutical Alliance (pCPA) Complete Negotiations for Multiple Sclerosis Treatment, OCREVUS® (ocrelizumab), for both RRMS and PPMS
MISSISSAUGA, ON, March 19, 2019 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) today announced that it has completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for a Letter...
Sep 13, 2018, 08:00 ET HERCEPTIN® (trastuzumab) subcutaneous (SC) formulation approved in Canada for the treatment of HER2-positive breast cancer
SC formulation takes two to five minutes to administer, rather than up to 90 minutes with the standard intravenous (IV) formulation MISSISSAUGA, ON, Sept. 13, 2018 /CNW/ - Hoffmann-La Roche Limited...
Aug 07, 2018, 08:00 ET Health Canada Approves HEMLIBRA® for Hemophilia A Patients with Inhibitors
HEMLIBRA is the first new treatment in almost 20 years for this most severe form of hemophilia1 and the only medicine that is self-injected once weekly MISSISSAUGA, ON, Aug. 7, 2018 /CNW/ -...
Aug 07, 2018, 08:00 ET Health Canada Approves HEMLIBRA® for Hemophilia A Patients with Inhibitors
HEMLIBRA is the first new treatment in almost 20 years for this most severe form of hemophilia1 and the only medicine that is self-injected once weekly MISSISSAUGA, ON, Aug. 7, 2018 /CNW/ -...
Jul 09, 2018, 08:00 ET Health Canada Approves GAZYVA® for Previously Untreated Advanced Follicular Lymphoma
GAZYVA is the first anti-CD20 treatment in 15 years for the most common subtype of indolent lymphoma.1 MISSISSAUGA, ON, July 9, 2018 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) announced today...
Feb 15, 2018, 08:00 ET Health Canada Approves OCREVUS® (ocrelizumab) for Canadians Living with Primary Progressive Multiple Sclerosis (PPMS)
OCREVUS is a new treatment for a rare and worsening form of MS that impacts 10-15 per cent of Canadians living with the disease1 MISSISSAUGA, ON, Feb. 15, 2018 /CNW/ - Hoffmann-La Roche Limited...
Nov 02, 2017, 08:00 ET Health Canada Approves ACTEMRA® (tocilizumab) for Canadians Living with Giant Cell Arteritis (GCA)
ACTEMRA® is the first non-steroid treatment designed to directly target the interleukin-6 (IL-6) receptor, offering a new option to treat GCA1 MISSISSAUGA, ON, Nov. 2, 2017 /CNW/ - Hoffmann-La Roche...
Oct 24, 2017, 09:00 ET Media Advisory/Photo Opportunity - Canadian Men's Relay Team Members Pass the Baton to Winnipeg to Fight IPF
Join Olympian Aaron Brown as he raises awareness of this fatal lung condition WINNIPEG, Oct. 24, 2017 /CNW/ - One of Canada's fastest sprinters, Aaron Brown, will make his mark this Sunday, October...
Oct 12, 2017, 11:23 ET MEDIA ADVISORY/PHOTO OPPORTUNITY: Canadian Men's Relay Team Members Pass the Baton to Vancouver to Fight IPF
Join Aaron Brown and Brendon Rodney as they raise awareness of this fatal lung condition VANCOUVER, Oct. 12, 2017 /CNW/ - Two of Canada's fastest sprinters, Aaron Brown and Brendon Rodney will make...
Oct 05, 2017, 10:00 ET Media Advisory/Photo Opportunity - Canadian Men's Relay Team Members Pass the Baton to Calgary to Fight IPF
Join Akeem Haynes and Brendon Rodney as they raise awareness of this fatal lung condition CALGARY, Oct. 5, 2017 /CNW/ - Two of Canada's fastest sprinters, Akeem Haynes and Brendon Rodney will make...
Sep 20, 2017, 07:30 ET Andre De Grasse and the Canadian Men's Relay Team Pass the Baton to Help Canadians Fight Idiopathic Pulmonary Fibrosis (IPF)
Join the team as they raise awareness of this rare, but fatal, lung condition MISSISSAUGA, ON, Sept. 20, 2017 /CNW/ - This fall, as part of the Roche Fight IPF Six-Minute Marathons initiative,...
Aug 15, 2017, 08:00 ET Health Canada Approves OCREVUS™ (ocrelizumab) for Canadians Living with Relapsing-Remitting Multiple Sclerosis (RRMS)
OCREVUS is a first-in-class treatment that targets B-cells, offering a new pathway to treat MS1 MISSISSAUGA, ON, Aug. 15, 2017 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) today announced that...
May 24, 2017, 17:03 ET Canadians with idiopathic pulmonary fibrosis participate in "six-minute marathon" to raise awareness of rare, but fatal lung disease(1)
Participants encourage others with the disease to learn more and stay active longer VICTORIA, May 24, 2017 /CNW/ - While many Canadians are lacing up their running shoes this spring to participate in ...
Feb 14, 2017, 08:00 ET Princess Margaret Cancer Centre champions Canadian excellence in health research on Roche global cancer research network
Partnership positions Princess Margaret Cancer Centre to provide Canadian perspective on a Network of 21 academic centres from around the world to access and share technology, data and expertise to...
Feb 07, 2017, 07:30 ET Health Canada Approves GAZYVA® for Patients with Previously Treated Follicular Lymphoma
New targeted treatment now available for Canadians living with the most common form of slow-growing, non-Hodgkin's lymphoma MISSISSAUGA, ON, Feb. 7, 2017 /CNW/ - Hoffmann-La Roche Limited (Roche...
Dec 13, 2016, 07:30 ET New formulation of RITUXAN now available to Canadians living with non-Hodgkin's Lymphoma
MISSISSAUGA, ON, Dec. 13, 2016 /CNW/ - Canadians living with non-Hodgkin's Lymphoma, one of the most commonly diagnosed blood cancers in Canada,1 now have a new option that may help them minimize...
Nov 15, 2016, 08:00 ET Grandchildren and parents unite to stand up to idiopathic pulmonary fibrosis (IPF) in a powerful vocal performance of chart-topping anthem 'Fight Song'
Canada participates in an international campaign to encourage people living with IPF to live for today and keep fighting their disease. MISSISSAUGA, ON, Nov. 15, 2016 /CNW/ - Just in time for Lung...
Oct 31, 2016, 07:45 ET Health Canada approves ALECENSARO™ - a targeted oral treatment - for patients with aggressive and rare form of lung cancer
Early data suggests ALECENSARO also shows strong efficacy in treating the spread of lung cancer to the brain, a critical unmet need for patients MISSISSAUGA, ON, Oct. 31, 2016 /CNW/ - Hoffmann-La...
Jun 24, 2016, 07:59 ET /R E P E A T -- Canadians with idiopathic pulmonary fibrosis participate in "six-minute marathon" to raise awareness of rare, but fatal lung disease[1]/
Participants encourage others with the disease to learn more and stay active longer TORONTO, June 21, 2016 /CNW/ - While many Canadians are lacing up their running shoes this summer to participate in ...
Jun 21, 2016, 09:00 ET Canadians with idiopathic pulmonary fibrosis participate in "six-minute marathon" to raise awareness of rare, but fatal lung disease[1]
Participants encourage others with the disease to learn more and stay active longer TORONTO, June 21, 2016 /CNW/ - While many Canadians are lacing up their running shoes this summer to participate in ...
Jun 11, 2016, 08:00 ET /R E P E A T -- Canadians with idiopathic pulmonary fibrosis participate in "six-minute marathon" to raise awareness of rare, but fatal lung disease(1)/
Participants encourage others with the disease to learn more and stay active longer CALGARY, June 8, 2016 /CNW/ - While many Canadians are lacing up their running shoes this summer to participate in...
Jun 08, 2016, 10:46 ET Canadians with idiopathic pulmonary fibrosis participate in "six-minute marathon" to raise awareness of rare, but fatal lung disease(1)
Participants encourage others with the disease to learn more and stay active longer CALGARY, June 8, 2016 /CNW/ - While many Canadians are lacing up their running shoes this summer to participate in...
Feb 25, 2016, 07:44 ET New targeted therapy for treatment of serious form of skin cancer approved in Canada
CotellicTM in combination with Zelboraf® designed to inhibit cancer growth in metastatic melanoma MISSISSAUGA, ON, Feb. 25, 2016 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) announced today that...
